- Home
- OKUR vs BRNS Comparison
OKUR vs BRNS Comparison
Compare OKUR & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKUR
- BRNS
- Stock Information
- Founded
- OKUR 2011
- BRNS 2016
- Country
- OKUR United States
- BRNS United Kingdom
- Employees
- OKUR N/A
- BRNS N/A
- Industry
- OKUR
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- OKUR
- BRNS Health Care
- Exchange
- OKUR NYSE
- BRNS Nasdaq
- Market Cap
- OKUR 34.9M
- BRNS 40.0M
- IPO Year
- OKUR N/A
- BRNS 2021
- Fundamental
- Price
- OKUR $2.35
- BRNS $0.87
- Analyst Decision
- OKUR Strong Buy
- BRNS Strong Buy
- Analyst Count
- OKUR 4
- BRNS 1
- Target Price
- OKUR $32.25
- BRNS $3.00
- AVG Volume (30 Days)
- OKUR 118.8K
- BRNS 39.4K
- Earning Date
- OKUR 08-14-2025
- BRNS 08-07-2025
- Dividend Yield
- OKUR N/A
- BRNS N/A
- EPS Growth
- OKUR N/A
- BRNS N/A
- EPS
- OKUR N/A
- BRNS N/A
- Revenue
- OKUR N/A
- BRNS $14,969,000.00
- Revenue This Year
- OKUR N/A
- BRNS N/A
- Revenue Next Year
- OKUR N/A
- BRNS N/A
- P/E Ratio
- OKUR N/A
- BRNS N/A
- Revenue Growth
- OKUR N/A
- BRNS 4381.74
- 52 Week Low
- OKUR $1.70
- BRNS $0.64
- 52 Week High
- OKUR $20.00
- BRNS $1.65
- Technical
- Relative Strength Index (RSI)
- OKUR N/A
- BRNS 44.19
- Support Level
- OKUR N/A
- BRNS $0.96
- Resistance Level
- OKUR N/A
- BRNS $0.93
- Average True Range (ATR)
- OKUR 0.00
- BRNS 0.06
- MACD
- OKUR 0.00
- BRNS -0.02
- Stochastic Oscillator
- OKUR 0.00
- BRNS 15.14
About OKUR ONKURE THERAPEUTICS INC
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.